[
    [
        {
            "time": "",
            "original_text": "医药生物行业周报：蓄力待发展望长期机遇",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "周报",
                    "蓄力",
                    "长期机遇"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业周报：蓄力待发展望长期机遇",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【国信医药丨行业重大事件快评】静丙艾滋抗体阳性事件尚需静待最终调查结果",
            "features": {
                "keywords": [
                    "国信医药",
                    "静丙",
                    "艾滋抗体",
                    "阳性",
                    "调查结果"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【国信医药丨行业重大事件快评】静丙艾滋抗体阳性事件尚需静待最终调查结果",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "头号研报：2018年A股业绩预告总结",
            "features": {
                "keywords": [
                    "头号研报",
                    "2018",
                    "A股",
                    "业绩预告",
                    "总结"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "A股"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "头号研报：2018年A股业绩预告总结",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "报告 | 2018年河南省上市公司市值TOP50",
            "features": {
                "keywords": [
                    "报告",
                    "2018",
                    "河南省",
                    "上市公司",
                    "市值",
                    "TOP50"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "河南省上市公司"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "报告 | 2018年河南省上市公司市值TOP50",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "A股迎春 暖意浓浓",
            "features": {
                "keywords": [
                    "A股",
                    "迎春",
                    "暖意浓浓"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "A股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股迎春 暖意浓浓",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-02-10",
            "original_text": "【医药】江琦、王超（研究助理）：2月月报：信心正逐步恢复、Q1建议关注创新药、原料药和商业板块 - 20190210",
            "features": {
                "keywords": [
                    "医药",
                    "江琦",
                    "王超",
                    "2月月报",
                    "信心恢复",
                    "创新药",
                    "原料药",
                    "商业板块"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "创新药",
                    "原料药",
                    "商业板块"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药】江琦、王超（研究助理）：2月月报：信心正逐步恢复、Q1建议关注创新药、原料药和商业板块 - 20190210",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "修美乐连续7年销量全球第一 潜在市场空间巨大(附股)",
            "features": {
                "keywords": [
                    "修美乐",
                    "销量",
                    "全球第一",
                    "潜在市场空间",
                    "附股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "修美乐连续7年销量全球第一 潜在市场空间巨大(附股)",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]